To validate the involvement of CD8+ T cells in the tumor-promoting role of ID1 expressing TAMs, we depleted CD8+ T cells using systemic administration of an anti-CD8β antibody in a CT26 s.c. model (Fig. 3j). This evidence concerns the gene CD8A and neoplasm.